Literature DB >> 2937369

Progressive symmetric erythrokeratodermia. Histological and ultrastructural study of patient before and after treatment with etretinate.

V Nazzaro, C Blanchet-Bardon.   

Abstract

Progressive symmetric erythrokeratodermia is a rare inherited cornification disorder characterized by symmetric erythematous hyperkeratotic plaques. Approximately 25 cases have been reported, but the ultrastructural features have not been well characterized. In this article, we describe the clinical, histologic, and ultrastructural findings noted in our patient. Biopsy specimens taken before treatment with etretinate showed hyperkeratosis with a well-preserved granular layer and acanthosis. Ultrastructural examination disclosed that granular cells contained markedly swollen mitochondria and that corneocytes contained many lipidlike vacuoles. After initiation of treatment, considerable clinical improvement was observed, but without significant histologic modification. The principal posttreatment ultrastructural changes observed were the reduction of mitochondrial swelling in granular cells and the reduction in the number of lipidlike vacuoles in corneocytes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2937369     DOI: 10.1001/archderm.122.4.434

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  3 in total

1.  The molecular pathology of progressive symmetric erythrokeratoderma: a frameshift mutation in the loricrin gene and perturbations in the cornified cell envelope.

Authors:  A Ishida-Yamamoto; J A McGrath; H Lam; H Iizuka; R A Friedman; A M Christiano
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

2.  Clinical, light and electron microscopic features of recessive ichthyosis congenita type III.

Authors:  K M Niemi; L Kanerva; C F Wahlgren; J Ignatius
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

3.  Progressive symmetrical erythrokeratodermia -- case report.

Authors:  Bianca de Mello Guaraldi; Thaís Jerez Jaime; Rafael de Mello Guaraldi; Daniel Fernandes Melo; Osvania Maris Nogueira; Nilton Rodrigues
Journal:  An Bras Dermatol       Date:  2013 Jan-Feb       Impact factor: 1.896

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.